Literature DB >> 19855244

Oleanolic Acid, a plant triterpenoid, significantly improves survival and function of islet allograft.

Angaswamy Nataraju1, Deepti Saini, Sabarinathan Ramachandran, Nicholas Benshoff, Wei Liu, William Chapman, Thalachallour Mohanakumar.   

Abstract

BACKGROUND.: Oleanolic acid (OA) is a ubiquitous triterpenoid, with potent antioxidant and anti-inflammatory properties. Here, we tested whether these combined properties of OA can prevent nonimmunologic primary nonfunctioning and immunologic phenomena ascribed to graft rejection hence prolong islet allograft survival. METHODS.: Islet transplants were performed under kidney capsule of streptozotocin-induced diabetic C57BL/6 mice with BALB/c islets. Recipients were treated with 0.5 mg/day of OA intraperitoneally, and serum samples were collected once in 2 days and used for luminex, ELISA, and donor-specific antibody screening. Transplanted mice were killed at different time intervals to obtain splenocytes and kidney samples for ELISPOT, mixed leukocyte reaction, and immunohistochemical studies. RESULTS.: After transplantation, the decrement of blood glucose was significantly faster in mice receiving OA less than 2+/-1 days compared with untreated (4+/-2 days). OA prolonged survival of transplanted islets up to 23+/-3 days and reversed diabetes even with 250 islets. Treatment group showed increased serum interleukin (IL)-10 (twofold) and decreased inducible protein-10 and IL-4 (threefold) in luminex. Significantly reduced frequency of interferon-gamma (4.5-fold), IL-4 (3.5-fold), IL-2 (2.3-fold), and IL-17 (fourfold) producing T-cell populations were found in ELISPOT. OA-treated grafts had significant reduced and delayed infiltration of CD4+ and CD8+ T cells. OA also delayed donor-specific antibody generation up to 19 days after transplantation. Combined treatment with cyclosporine A, OA further prolonged the islet allograft survival to 34+/-3 days. CONCLUSIONS.: In conclusion, OA is an attractive, dietary nontoxic plant triterpenoid, which suppresses the production of proinflammatory cytokines and delays graft-specific immune responses to prolong islet allograft survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19855244      PMCID: PMC2769028          DOI: 10.1097/TP.0b013e3181b9cbc4

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  56 in total

1.  NK cells, macrophages, and humoral immune responses are dominant in primary nonfunction of islet grafts in the dog-to-rat xenotransplant model.

Authors:  S Deng; R J Ketchum; T Kucher; M Weber; A Naji; K L Brayman
Journal:  Transplant Proc       Date:  1997-06       Impact factor: 1.066

Review 2.  Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.

Authors:  Neal R Barshes; Samuel Wyllie; John A Goss
Journal:  J Leukoc Biol       Date:  2005-02-22       Impact factor: 4.962

3.  Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress.

Authors:  Albena T Dinkova-Kostova; Karen T Liby; Katherine K Stephenson; W David Holtzclaw; Xiangqun Gao; Nanjoo Suh; Charlotte Williams; Renee Risingsong; Tadashi Honda; Gordon W Gribble; Michael B Sporn; Paul Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

4.  Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients.

Authors:  André Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
Journal:  Breast Cancer Res Treat       Date:  2004-11       Impact factor: 4.872

5.  Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay.

Authors:  R T Carson; D A Vignali
Journal:  J Immunol Methods       Date:  1999-07-30       Impact factor: 2.303

6.  Five-year follow-up after clinical islet transplantation.

Authors:  Edmond A Ryan; Breay W Paty; Peter A Senior; David Bigam; Eman Alfadhli; Norman M Kneteman; Jonathan R T Lakey; A M James Shapiro
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

Review 7.  Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.

Authors:  A Rabinovitch; W L Suarez-Pinzon
Journal:  Biochem Pharmacol       Date:  1998-04-15       Impact factor: 5.858

8.  Anti-inflammatory activity of oleanolic acid by inhibition of secretory phospholipase A2.

Authors:  Kattepura K Dharmappa; Raju Venkatesh Kumar; Angaswamy Nataraju; Riyaz Mohamed; Holenarasipura V Shivaprasad; Bannikuppe S Vishwanath
Journal:  Planta Med       Date:  2008-12-11       Impact factor: 3.352

9.  Antidiabetic principles of natural medicines. III. Structure-related inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity.

Authors:  H Matsuda; Y Li; T Murakami; N Matsumura; J Yamahara; M Yoshikawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1998-09       Impact factor: 1.645

Review 10.  An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.

Authors:  A Rabinovitch
Journal:  Diabetes Metab Rev       Date:  1998-06
View more
  5 in total

1.  Oleanolic acid attenuates renal fibrosis in mice with unilateral ureteral obstruction via facilitating nuclear translocation of Nrf2.

Authors:  Sungjin Chung; Hye Eun Yoon; Soo Jeong Kim; Sung Jun Kim; Eun Sil Koh; Yu Ah Hong; Cheol Whee Park; Yoon Sik Chang; Seok Joon Shin
Journal:  Nutr Metab (Lond)       Date:  2014-01-06       Impact factor: 4.169

Review 2.  Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes.

Authors:  Jose M Castellano; Angeles Guinda; Teresa Delgado; Mirela Rada; Jose A Cayuela
Journal:  Diabetes       Date:  2013-06       Impact factor: 9.461

3.  Oleanolic acid reduces hyperglycemia beyond treatment period with Akt/FoxO1-induced suppression of hepatic gluconeogenesis in type-2 diabetic mice.

Authors:  Xiao-Yi Zeng; Yi-Ping Wang; James Cantley; Tristan J Iseli; Juan Carlos Molero; Bronwyn D Hegarty; Edward W Kraegen; Yang Ye; Ji-Ming Ye
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

4.  Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling.

Authors:  Yu Ah Hong; Ji Hee Lim; Min Young Kim; Eun Nim Kim; Eun Sil Koh; Seok Joon Shin; Bum Soon Choi; Cheol Whee Park; Yoon Sik Chang; Sungjin Chung
Journal:  J Transl Med       Date:  2014-02-21       Impact factor: 5.531

Review 5.  Oleanolic Acid: Extraction, Characterization and Biological Activity.

Authors:  José M Castellano; Sara Ramos-Romero; Javier S Perona
Journal:  Nutrients       Date:  2022-01-31       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.